Using Patient-Derived Organoids to Predict Locally Advanced or Metastatic Lung Cancer Tumor Response A Real-World Study
[Cell Rep Med] Cancer organ drug sensitivity testing accurately predicts the clinical response of advanced cancer patients to treatment.
français 
Deutsch 
Español 
italiano 
русский 
português 
العربية 
Nederland